[1] Heo JS, Choi Y, Kim HS, et al. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue[J]. Int J Mol Med, 2016, 37: 115-125. [2] 范瑛,庄晨,宋坪.基于干细胞探讨开通玄府、补肾培元法治疗银屑病[J].北京中医药,2015,34:310-312. [3] 安星燕,陈云飞,李娜,等.现代细胞生物学研究诠释三焦器官/间充质干细胞系统的医学实质[J].基础医学与临床,2018,38:1599-1605. [4] 王剑男.《黄帝内经》肾藏象理论集注与整理研究[D].呼和浩特:内蒙古医科大学,2021:2-3. [5] 颜莹,杨京华,翁泽林.“三焦为原气之别使”刍议[J].四川中医,2021,39:23-26. [6] 余亚娜,于建春,韩景献. 三焦气化与肾的相关性[C].2010年中国针灸学会脑病专业委员会、中国针灸学会循证针灸专业委员会学术大会论文集,2010:259-262. [7] Liu J, Gao J, Liang Z, et al. Mesenchymal stem cells and their microenvironment[J]. Stem Cell Res Ther, 2022, 13: 429. [8] Glenn JD, Whartenby KA. Mesenchymal stem cells:Emerg-ing mechanisms of immunomodulation and therapy[J]. World J Stem Cells, 2014, 6: 526-39. [9] 原林,王军.筋膜学[M].北京:人民卫生出版社,2018:105-118,239. [10] Najar M, Raicevic G, Id Boufker H, et al. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions[J]. Exp Hematol, 2010, 38: 922-932. [11] Najar M, Raicevic G, Crompot E, et al. The immunomodulatory potential of mesenchymal stromal cells[J]. J Immunother, 2016, 39: 45-59. [12] Wang S, Lei B, Zhang E, et al. Targeted therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics[J]. Int J Nanomed, 2022, 17:1757-1781. [13] Xu C, Yu P, Han X, et al. TGF-b promotes immune responses in the presence of mesenchymal stem cells[J]. J Immunol, 2014, 192: 103-109. [14] Ayala-Cuellar AP, Kang JH, Jeung EB,et al.Roles of mesenchymal stem cells in tissue regeneration and immunomodulation[J]. Biomol Ther, 2019, 27: 25-33. [15] Mezey É.Human mesenchymal stem/stromal cells in immune regulation and therapy[J]. Stem Cells Transl Med, 2022, 11: 114-134. [16] Yuan L, Wu MJ, Sun HY, et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury[J]. Am J Physiol Renal Physiol, 2011, 300: 207-218. [17] 黄建华,卞琴,沈自尹.“肾精”涵义的再分析及其意义[J].中华中医药杂志,2012,27:522-524. [18] 柴倩云,尹秀平,朱榕嘉,等.从间充质干细胞调控免疫平衡作用探讨中医扶正祛邪治疗银屑病[J].中医杂志,2019,60:206-209. [19] 史志云.关于三焦实质与三焦辨证[J].广州中医学院学报,1985:34-38+43. [20] 王琦,白明华.中医药治疗新型冠状病毒肺炎恢复期面临的问题和对策[J].中医杂志,2021,62:371-374+380. [21] Zhu Y, Zhu R, Liu K, et al. Human umbilical cord mesenchymal stem cells for adjuvant treatment of a critically Ⅲ COVID-19 patient: a case report[J].Infect Drug Resist, 2020, 13: 3295-3300. [22] Leng Z, Yin D, Zhao Z, et al. A survey of 434 clinical trials about coronavirus disease 2019 in China[J]. J Med Virol, 2020, 92: 1715-1717. [23] Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia[J]. Aging Dis, 2020, 11, 216-228. [24] Yu H, Yang X, Xiao X, et al. Human adipose mesenchymal stem cell-derived exosomes protect mice from DSS-induced inflammatory bowel disease by promoting intestinal-stem-cell and epithelial regeneration[J]. Aging Dis, 2021, 12: 1423-1437. [25] Wang L, Han Q, Chen H, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis[J]. Stem Cells Dev, 2014, 23: 2482-2489. [26] 尹秀平. 从巴戟天多糖对银屑病AMSCs免疫调控的干预探讨“补肾培元”法治疗银屑病的作用机制[D].北京:中国中医科学院,2017:55-65. [27] 张晓彤.从脂肪间充质干细胞对HaCat炎症模型的免疫调控作用探讨补益法治疗银屑病机制[D].北京:中国中医科学院,2020:64-67. [28] 张晓彤,高云逸,宋坪.寻常型银屑病中医辨证特点概况及思考[J].中医杂志,2019,60:1732-1736. [29] 张乃月,朱榕嘉,尹秀平,等.射干苷和桃叶珊瑚苷抑制LPS诱导的人脂肪间充质干细胞炎性反应[J].基础医学与临床,2019,39:961-966. [30] Niu Y, Chen Y, Xu H, et al. Astragaloside IV promotes antiphotoaging by enhancing the proliferation and paracr-ine activity of adipose-derived stem cells[J]. Stem Cells Dev, 2020, 29: 1285-1293. |